These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 9414172

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang N, Shao Y, Wu Z, Liu G, Wang X, Sun Z.
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [Abstract] [Full Text] [Related]

  • 4. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC, Kleiner DE, Axiotis CA, Di Bisceglie A, Nomura AM, Stemmermann GN, Tabor E.
    J Natl Cancer Inst; 1992 Nov 04; 84(21):1638-41. PubMed ID: 1279184
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC, Umbach DM, Yu MC, London SJ, Zhang ZQ, Taylor JA.
    Cancer Epidemiol Biomarkers Prev; 2001 Jun 04; 10(6):617-25. PubMed ID: 11401911
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
    Ndububa DA, Yakicier CM, Ojo OS, Adeodu OO, Rotimi O, Ogunbiyi O, Ozturk M.
    Afr J Med Med Sci; 2001 Jun 04; 30(1-2):125-7. PubMed ID: 14510167
    [Abstract] [Full Text] [Related]

  • 10. Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.
    Wild CP, Jansen LA, Cova L, Montesano R.
    Environ Health Perspect; 1993 Mar 04; 99():115-22. PubMed ID: 8391433
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
    Kuang SY, Lekawanvijit S, Maneekarn N, Thongsawat S, Brodovicz K, Nelson K, Groopman JD.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb 04; 14(2):380-4. PubMed ID: 15734961
    [Abstract] [Full Text] [Related]

  • 12. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY, Santella RM.
    Cancer Res; 1997 Aug 15; 57(16):3471-7. PubMed ID: 9270015
    [Abstract] [Full Text] [Related]

  • 13. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N, Lai P, Pang E, Fung LF, Sheng Z, Wong V, Wang W, Hayashi Y, Perlman E, Yuna S, Lau JW, Johnson PJ.
    Clin Cancer Res; 2000 Oct 15; 6(10):4000-9. PubMed ID: 11051249
    [Abstract] [Full Text] [Related]

  • 14. Aflatoxin and liver cancer.
    Jackson PE, Groopman JD.
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec 15; 13(4):545-55. PubMed ID: 10654919
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
    Soini Y, Chia SC, Bennett WP, Groopman JD, Wang JS, DeBenedetti VM, Cawley H, Welsh JA, Hansen C, Bergasa NV, Jones EA, DiBisceglie AM, Trivers GE, Sandoval CA, Calderon IE, Munoz Espinosa LE, Harris CC.
    Carcinogenesis; 1996 May 15; 17(5):1007-12. PubMed ID: 8640905
    [Abstract] [Full Text] [Related]

  • 17. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
    Wild CP, Montesano R.
    Cancer Lett; 2009 Dec 01; 286(1):22-8. PubMed ID: 19345001
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K, Chen JG, Cui Y, Gong YY, Turner PC, Villar S, Wild CP, Parkin DM, Hainaut P.
    Cancer Epidemiol Biomarkers Prev; 2009 May 01; 18(5):1638-43. PubMed ID: 19366907
    [Abstract] [Full Text] [Related]

  • 20. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA.
    IARC Sci Publ; 1984 May 01; (63):167-79. PubMed ID: 6100268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.